Distinct overexpression of Fas ligand on T lymphocytes in aplastic anemia
- PMID: 16212902
Distinct overexpression of Fas ligand on T lymphocytes in aplastic anemia
Abstract
Increased expression of Fas by hematopoietic progenitors in aplastic anemia (AA) suggests that Fas/Fas ligand (FasL) system plays a key role in the formation of severe pancytopenia. To further confirm the above hypothesis, T cells from 8 patients with AA were systematically studied for their FasL's distribution pattern, releasing manner and proapoptotic activity, compared with normal resting T cells and artificially activated T cell blasts. The results demonstrated that AA T cells abnormally expressed low levels of membrane-bound FasL and contained high levels of intracellular FasL which could be triggered to release by high-dose phytohemagglutinin (PHA) pulse-stimulation. The supernatants from the PHA-stimulated AA T cells had apparent cytotoxicity against FasL-sensitive Jurkat cells, which could be significantly inhibited by monoclonal antibody against FasL in a dose-dependent manner, or nearly completely abrogated by ultracentrifugation. The above phenomena also appeared on artificially activated T cell blasts, but this was not the case on normal resting T cells. These results indicate that AA T cell is a type of "preactivated" T lymphocyte, characterized by overexpression of FasL, especially intracellular FasL which can be stimulated to release in bioactive exosomes-bound form. Taken together, our data provide further and direct evidence for the hypothesis that T cells might mediate the destruction of hematopoietic progenitor in AA through Fas/FasL system.
Similar articles
-
Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.Cell Immunol. 2006 Feb;239(2):121-8. doi: 10.1016/j.cellimm.2006.05.003. Epub 2006 Jun 30. Cell Immunol. 2006. PMID: 16808908
-
FASL -844C polymorphism is associated with increased activation-induced T cell death and risk of cervical cancer.J Exp Med. 2005 Oct 3;202(7):967-74. doi: 10.1084/jem.20050707. Epub 2005 Sep 26. J Exp Med. 2005. PMID: 16186185 Free PMC article.
-
Activated human T cells release bioactive Fas ligand and APO2 ligand in microvesicles.J Immunol. 1999 Aug 1;163(3):1274-81. J Immunol. 1999. PMID: 10415024
-
Impaired apoptosis and immune senescence - cause or effect?Immunol Rev. 2005 Jun;205:130-46. doi: 10.1111/j.0105-2896.2005.00270.x. Immunol Rev. 2005. PMID: 15882350 Review.
-
Considering Fas ligand as a target for therapy.Expert Opin Ther Targets. 2005 Feb;9(1):119-34. doi: 10.1517/14728222.9.1.119. Expert Opin Ther Targets. 2005. PMID: 15757486 Review.
Cited by
-
Clinical study on combined "lanzhou prescription" for the treatment of "syndrome of heat-toxin congestion and excessiveness" in children with acute aplastic anemias.Afr Health Sci. 2023 Jun;23(2):709-714. doi: 10.4314/ahs.v23i2.81. Afr Health Sci. 2023. PMID: 38223589 Free PMC article.
-
Lymphocytes with aberrant expression of Fas or Fas ligand attenuate immune bone marrow failure in a mouse model.J Immunol. 2009 Mar 15;182(6):3414-22. doi: 10.4049/jimmunol.0801430. J Immunol. 2009. PMID: 19265119 Free PMC article.
-
The role of the Th1 transcription factor T-bet in a mouse model of immune-mediated bone-marrow failure.Blood. 2010 Jan 21;115(3):541-8. doi: 10.1182/blood-2009-03-211383. Epub 2009 Nov 10. Blood. 2010. PMID: 19903901 Free PMC article.
-
Role of perforin-mediated cell apoptosis in murine models of infusion-induced bone marrow failure.Exp Hematol. 2009 Apr;37(4):477-86. doi: 10.1016/j.exphem.2008.12.001. Epub 2009 Feb 12. Exp Hematol. 2009. PMID: 19216020 Free PMC article.
-
Primitive Sca-1 Positive Bone Marrow HSC in Mouse Model of Aplastic Anemia: A Comparative Study through Flowcytometric Analysis and Scanning Electron Microscopy.Stem Cells Int. 2010;2010:614395. doi: 10.4061/2010/614395. Epub 2009 Oct 28. Stem Cells Int. 2010. PMID: 21048851 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous